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Abstract
Recently, multi-task based feature selection methods have been used in multi-modality based 
classification of Alzheimer’s disease (AD) and its prodromal stage, i.e., mild cognitive impairment 
(MCI). However, in traditional multi-task feature selection methods, some useful discriminative 
information among subjects is usually not well mined for further improving the subsequent 
classification performance. Accordingly, in this paper, we propose a discriminative multitask 
feature selection method to select the most discriminative features for multi-modality based 
classification of AD/MCI. Specifically, for each modality, we train a linear regression model using 
the corresponding modality of data, and further enforce the group-sparsity regularization on 
weights of those regression models for joint selection of common features across multiple 
modalities. Furthermore, we propose a discriminative regularization term based on the intra-class 
and inter-class Laplacian matrices to better use the discriminative information among subjects. To 
evaluate our proposed method, we perform extensive experiments on 202 subjects, including 51 
AD patients, 99 MCI patients, and 52 healthy controls (HC), from the baseline MRI and FDG-
PET image data of the Alzheimer’s Disease Neuroimaging Initiative (ADNI). The experimental 
results show that our proposed method not only improves the classification performance, but also 
has potential to discover the disease-related biomarkers useful for diagnosis of disease, along with 
the comparison to several state-of-the-art methods for multi-modality based AD/MCI 
classification.
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Introduction
As the common form of dementia worldwide, Alzheimer’s disease (AD) is a primary 
neurodegenerative brain disease occurring in elderly people. It was first described by a 
German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after 
him (Berchtold and Cotman 1998). It was reported that there were 26.6 million AD patients 
in the world in 2006 (Berchtold and Cotman 1998). Also, it is predicted that 1 in 85 people 
will be affected by AD by 2050 (Brookmeyer et al. 2007). There is a prodromal state 
between normal aging and AD, called mild cognitive impairment (MCI). Most individuals 
with MCI will eventually progress to dementia within 5 years (Gauthier et al. 2006). There 
is no cure for AD and no treatment to reverse or halt its progression. Therefore, accurate 
diagnosis of AD and MCI is very important to delay the disease progression. However, since 
the change of AD-related brain is prior to the symptom of AD, it is critical to detect those 
changes for early diagnosis of AD. Recently, neuroimaging technology is increasingly used 
to identify such abnormal changes in the early stage of AD (Cheng et al. 2012; Petersen et 
al. 1999; Sui et al. 2012; Ye et al. 2011; Zhang et al. 2011).
Early studies on AD/MCI classification mainly focus on using a single modality of 
biomarker, such as magnetic resonance imaging (MRI) (De Leon et al. 2007; Fan et al. 
2008; McEvoy et al. 2009), fluorodeoxyglucose positron emission tomography (FDG-PET) 
(Higdon et al. 2004; Morris et al. 2001; De Santi et al. 2001), cerebrospinal fluid (CSF) 
(Mattsson et al. 2009; Shaw et al. 2009), etc. However, in those studies, some useful 
complementary information across different modalities of biomarkers is ignored, which is 
helpful for further improving the accuracy of classification. Recently, several researchers 
have explored to combine multiple modalities of biomarkers (Apostolova et al. 2010; Fjell et 
al. 2010; Landau et al. 2010; Walhovd et al. 2010; Jie et al. 2013). For instance, Hinrichs et 
al. (Hinrichs et al. 2009) combined two modalities, i.e., MRI and PET, for classification of 
AD. Bouwman et al. (Bouwman et al. 2007) proposed to combine two modalities of MRI 
and CSF to identify MCI patients from healthy controls (HC). Fellgiebel et al. (Fellgiebel et 
al. 2007) used PET and CSF to predict cognitive deterioration in MCI. Zhang et al. (Zhang 
et al. 2011) combined three modalities, i.e., MRI, FDG-PET and CSF, to classify AD/MCI 
from HC. Gray et al. (Gray et al. 2013) used four modalities, i.e., MRI, FDG-PET, CSF and 
genetic information, for AD classification. These existing studies have suggested that 
different modalities of biomarkers can provide the inherently complementary information 
that can improve accuracy in disease diagnosis when used together (Apostolova et al. 2010; 
Fjell et al. 2010; Landau et al. 2010; Walhovd et al. 2010; Foster et al. 2007).
In multi-modality based classification methods, traditional feature selection approaches, 
such as the least absolute shrinkage and selection operator (Lasso) and t-test, are often 
performed to help select the disease-related brain features for training a good learning model 
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(Tibshirani 1996; Wee et al. 2012). However, one main disadvantage of those feature 
selection methods is that they usually ignore the inherent relatedness among features from 
different modalities. Recently, multi-modality based feature selection methods have been 
proposed to overcome this problem. For example, Huang et al. (Huang et al. 2011) presented 
a sparse composite linear discrimination analysis to recognized AD-related ROIs from 
multi-modality data. Liu et al. (Liu et al. 2014) proposed a multi-task based feature selection 
with each task corresponding to a learning model using individual modality of data and 
embedding inter-modality information into multitask learning model for AD classification. 
Gray et al. (Gray et al. 2013) constructed a multi-modality classification framework based 
on pairwise similarity measures which come from random forest classifiers for the 
classification between AD/MCI and HC. However, in those methods, some useful 
discriminative information, such as the distribution information of intra-class and inter-class 
subjects, is not well mined, which may affect the final classification performance.
To address that problem, in this paper, we propose a new discriminative multi-task feature 
selection (DMTFS) model, which considers both the inherent relations among multimodality 
data and the distribution information of intra-class subjects (i.e., subjects from the same 
class) and inter-class subjects (i.e., subjects from different classes) from each modality. 
Specifically, we first formulate feature selection on multi-modality data as multi-task 
learning problem with each task corresponding to a learning problem on individual modality. 
Then, two regularized terms are included into the proposed DMTFS model. Specifically, the 
first term is the group-sparsity regularizer (Ng and Abugharbieh 2011; Yuan and Lin 2006), 
which ensures only a small number of common brain region-specific features to be jointly 
selected from multimodality data. Furthermore, we introduce a new Laplacian regularization 
term into the proposed objective function, which preserves the compactness of intra-class 
subjects and the separability of inter-class subjects, and hence induces the more 
discriminative features. Finally, we adopt the multi-kernel support vector machine (SVM) 
technique to fuse multi-modality data for performing classification of AD/MCI. To evaluate 
the proposed method, a series of experiments are performed on the baseline MRI and FDG-
PET image data of 202 subjects from the Alzheimer’s Disease Neuroimaging Initiative 
(ADNI), which includes 51 AD patients, 99 MCI patients, and 52 HC. The experimental 
results show the superiority of our proposed method, in comparison with the existing multi-
modality based methods.
Methods
Figure 1 shows the overview of our proposed framework, which contains three major steps, 
i.e., image pre-processing and feature extraction, discriminative multi-task feature selection, 
and multi-kernel SVM classification. In this section, before giving the detailed descriptions 
of these steps, we will first introduce the subjects used in this study.
Subjects
The dataset we used in this study is obtained from the Alzheimer’s Disease Neuroimaging 
Initiative (ADNI) database (www.adni-info.org). ADNI is a non-profit organization which 
was founded in 2003 by the National Institute of Biomedical Imaging and Bioengineering. 
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Many researchers of institutions work together to achieve this organization. The ADNI is 
committed to evaluate the progression of early Alzheimer’s disease, i.e., MCI, by combining 
some technology such as magnetic resonance imaging (MRI), fluorodeoxyglucose positron 
emission tomography (FDG-PET), Cerebrospinal fluid (CSF) and other clinical diagnosis, 
which greatly improve the efficiency of diagnosis, and save the time of treatment and the 
cost to the patients.
Following our previous works (Zhang et al. 2011, 2012), we evaluate the proposed method 
on the baseline MRI and FDG-PET data of 202 ADNI subjects, which contain 51 AD 
patients, 99 MCI patients (including 43 MCI converters (MCI-C) and 56 MCI non-
converters (MCI-NC)), as well as 52 healthy controls (HC). Specifically, we build multiple 
binary classifiers to confirm the classification performance of our proposed method, 
including AD vs. HC, MCI vs. HC, and MCI-C vs. MCI-NC.
Image Pre-processing and feature extraction
The same image pre-processing as in (Zhang et al. 2011, 2012) is performed for all MRI and 
PET images, including anterior commissure (AC) - posterior commissure (PC) correction, 
skull-stripping, removal of cerebellum, and segmentation of structural MR images into three 
different tissues: grey matter (GM), white matter (WM), and cerebrospinal fluid (CSF). With 
atlas warping, we can partition each subject image into 93 regions of interests (ROIs). For 
each of the 93 ROIs, we compute the GM tissue volume from the subject’s MRI image. For 
PET image, we first rigidly align it with its respective MRI image of the same subject, and 
then compute the average value of PET signals in each ROI. Therefore, for each subject, we 
can finally obtain totally 93 features from MRI image and another 93 features from PET 
image.
Discriminative Multi-Task Feature Selection (DMTFS)
Before deriving our proposed discriminative multi-task feature selection (DMTFS) method, 
we first briefly introduce the traditional multi-task feature selection (MTFS) model (Zhang 
et al. 2012). Suppose  as training subjects from the m 
-th modality (i.e., task), and Y=[y1, …, yi, …, yN]T∈RN represents the corresponding 
response vector from all training subjects, where d and N are the numbers of features and 
training subjects, respectively. Here,  is a feature vector of the i -th subject from the m -th 
modality, and yi∈{+1,−1} is the response class label (i.e., patient or healthy control). In 
addition, wm∈Rd represents the weight vector of linear function for the m -th task, and 
W=[w1, …, wm, …, wM]∈Rd×M denotes the weight matrix including all wm. Then, the 
MTFS model is to optimize the following objective function:
(1)
where M is the number of modalities,  the l2,1 -norm of weight matrix 
which calculates the sum of l2 -norm of wj (Yuan and Lin 2006), and wj is the j-th row of W 
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which represents the weight vector of the j -th feature across M tasks. Here, the l2,1 -norm is 
adopted to enforce the group sparsity on the weight matrix, i.e., encouraging a number of 
rows in the weight matrix being zero. The first term in Eq. (1) is the empirical loss function, 
which measures the error between predicted value obtained from learning model and the true 
value. λ is a regularization parameter which balances the relative importance of both terms. 
The larger λ value means the more zero rows appear in the weight matrix, i.e., few of 
features are preserved.
In MTFS model, a linear function (i.e., f(x)=wTx) was used to map the data from the original 
high-dimensional feature space to one-dimensional space. This model only focuses on the 
relationship between label and subject, and thus ignores the distribution information of 
subjects from each modality, such as the compactness of intra-class subjects and the 
separability of inter-class subjects. This kind of information may help induce the more 
discriminative features and thus further improve the classification performance. Figure 2 
illustrates an example. Here each color denotes a class, and the points with the same color 
denote that they come from the same class. The arrows with green color denote that green 
points (which are intra-class nearest neighbors) should be closer to the central green point in 
the new feature space. Also, the arrows with purple color denote that purple points (which 
are inter-class nearest neighbors) should be far away from the central green point in the new 
feature space. Intuitively, Fig. 2 shows that intra-class samples should be closer while inter-
class samples should be far away in the new feature space.
To address this problem, inspired by some recent works (Cai et al. 2007; Xue et al. 2009), 
we propose a new discriminative regularization term to preserve the distribution information 
of subjects. To be specific, in each modality, for each subject , we first seek its k nearest 
neighbors, i.e., , and define two disjoint subject subsets 
as follows:
(2)
(3)
where  includes the neighbors that have the same label with the subject , and 
 contains the neighbors having different labels with the subject . Then, to 
discover discriminative structure and geometrical information of the data, we construct two 
graphs, i.e., intra-class graph  and inter-class graph , with each subject as a node for 
both graphs. Let  and  denote the weight matrices of  and , respectively. We 
define:
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(4)
(5)
Then, to preserve the discriminative and structural information of two graphs during linear 
mapping, we introduce a new discriminative regularization term as:
(6)
Where
(7)
and
(8)
Here,  and  represent intra-class and inter-class Laplacian 
matrices for the m-th modality, respectively.  and  are 
the corresponding diagonal matrices. σ is a positive constant which controls the relative 
importance of both terms.
With the regularizer in Eq. (6), our proposed discriminative multi-task feature selection 
model (DMTFS) has the following objective function:
(9)
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where λ and σ are positive constants whose values can be determined via inner cross-
validation on the training data. Below, we give an algorithm to solve the optimization 
problem in Eq. (9).
Optimization algorithm
In our study, we use the Accelerated Proximal Gradient (APG) technique (Chen et al. 2009; 
Liu 2999) to solve the optimization problem in Eq. (9). Specifically, we first separate the 
objective function in Eq. (9) into a non-smooth part as:
(10)
and a smooth one as:
(11)
Then, the function h(W)+g(W) can be approximately expressed by the following function:
(12)
where ||·||F denotes the Frobenius norm, h(Wk) represents the gradient of h(W) at the point 
Wk in the k -th iteration process, and 〈W−Wk, ∇h(Wk)〉 denotes the inter product of matrixes 
which equals to Tr((W−Wk)T∇h(Wk)). Here, n represents the iteration step size, whose value 
can be decided by using line search.
Finally, the iterative process of APG algorithm can be interpreted as follows:
(13)
Where . According to (Chen et al. 2009; Liu 2999), we can decompose 
the problem in Eq. (13) into d separate sub-problems, for which the analytical solutions can 
be easily obtained. Also, from (Chen et al. 2009; Liu 2999), instead of performing gradient 
descent based on Wk, we can compute the following formulation as:
(14)
where  and .
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Multi-kernel SVM classification
After selecting the discriminative and common features (i.e., brain regions) across multiple 
modalities, we then use the multi-kernel SVM method proposed in (Zhang et al. 2011) for 
final classification of AD/MCI from healthy controls. Specifically, based on the features 
obtained from the proposed method, we compute a linear kernel across different subjects for 
each modality and then use the following function to integrate the multiple kernels:
(15)
where  represents the kernel function over the m -th modality between the 
sample xi and xj, and αm ≥ 0 is a weight parameter with constraint of Σmαm =1. Here, we 
find the optimal values of αm by using a coarse-grid search on the training subjects with 
range from 0 to 1 and the interval value of 0.1. Finally, the LIBSVM tool-box (Chang and 
Lin 2011) is adopted to perform SVM with the mixed kernel defined in Eq. (15).
Results
Classification performance
In this paper, we adopt 10-fold cross-validation to evaluate the classification performance. 
Specifically, we divide the whole samples into 10 parts, leaving one part for testing and the 
remaining parts as training data in each cross-validation. This process is repeated for 10 
independent times to avoid the bias in random partition of samples. Four performance 
measures, including classification accuracy (ACC) measuring the proportion of subjects 
correctly classified among the whole subjects, sensitivity (SEN) measuring the proportion of 
AD or MCI patients correctly classified, specificity (SPE) measuring the proportion of 
healthy controls correctly classified, and the area under receiver operating characteristic 
(ROC) curve (AUC), are used to evaluate the classification performance of different 
classification methods.
We compare our proposed DMTFS method with several other methods, including multi-task 
feature selection method (denoted as MTFS) (Zhang et al. 2012), and multi-modal 
classification method proposed in (Zhang et al. 2011) using the least absolution shrinkage 
and selection operator (Lasso) as feature selection (denoted as MML). For further 
comparison, we also concatenate the MRI and PET features into a long feature vector, 
followed by the sequential forward floating selection (SFFS) (Pudil et al. 1994) for feature 
selection, and then using the standard SVM for classification. Table 1 lists the comparison of 
different methods for AD/MCI classifications. Figure 3 plots the ROC curves of different 
methods.
From Table 1 and Fig. 3, we can see that our proposed method outperforms the other 
methods in all performance measures for both AD and MCI classifications. Specifically, our 
method achieves the classification accuracies of 95.92 % and 82.13 % for AD vs. HC and 
MCI vs. HC, respectively, while the best accuracies of other methods are only 92.07 % and 
74.17 %, respectively. In addition, our method achieves high AUC values of 0.97 and 0.82 
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for AD vs. HC and MCI vs. HC, respectively, showing better diagnostic power than the 
other methods for AD/MCI classifications.
On the other hand, we also perform experiments on classifying MCI converters (MCI-C) 
from MCI non-converters (MCI-NC), with the corresponding results shown in Table 2 and 
Fig. 4. As can be seen from Table 2 and Fig. 4, our proposed method achieves better 
classification performances than other methods for MCI-C vs. MCI-NC classification. 
Specifically, our proposed method achieves a classification accuracy of 71.12 % for MCI-C 
vs. MCI-NC classification, which is nearly 10 % higher than the best result by other 
methods.
In addition, we perform significance test on the classification performances between our 
proposed method and other compared methods by using the standard paired t test under the 
significance level of 95 %. Table 3 shows the results of t test between our method and any 
other method. As we can see from Table 3, for all the three classification tasks, i.e., AD vs. 
HC, MCI vs. HC, and MCI-C vs. MCI-NC, our proposed method is significantly better than 
other compared methods, which again shows the advantages of our proposed method.
The most discriminative brain regions
Because of the importance of the brain region-related disease in early diagnosis, we besides 
reporting classification performances, and also investigate the top selected features (i.e., 
brain regions) by our proposed DMTFS method. To be specific, since the selected features in 
each cross-validation are not the same, we select those features as the most discriminative 
features which have the highest occurrence frequency in every cross-validation folds.
Figure 5 plots the top 15 selected brain regions for MCI vs. HC classification. As can be 
seen from Fig. 5, our method can effectively identify those disease-related brain regions 
such as hippocampal, amygdala, precuneus, and temporal pole, which have been reported to 
be relevant with AD in the previous studies (Dai et al. 2009; Del Sole et al. 2008; Misra et 
al. 2009; Solodkin et al. 2013; Van Hoesen and Hyman 1990; Wang et al. 2012). For 
example, hippocampus are located in the temporal lobe of the brain, which are the role of the 
memory and spatial navigation. The Hippocampi are the first damaged regions in AD, 
showing loss of memory and spatial orientation. Hyman BT et al. (Hyman et al. 1984) also 
mentioned that the focal pattern of pathology isolates the hippocampal may induce to 
damage of memory in AD. Amygdala is the subcortical central of the limbic system, and has 
the function of regulating visceral sensation and producing emotions. Many researchers have 
found that the important role of amygdala in AD patients (Knafo et al. 2009; Poulin et al. 
2011). Such as Knafo et al. (Knafo et al. 2009) mentioned that individuals who have AD 
with a significant shrinkage of amygdala, and extensive gliosis. In addition, precuneus (Del 
Sole et al. 2008; Karas et al. 2007) and temporal pole (Nobili et al. 2008) also show 
significant abnormalities in AD.
Discussion
In this paper, we propose a new discriminative multi-task feature selection method for AD 
vs. HC, MCI vs. HC, and MCI-C vs. MCI-NC classifications. Experimental results 
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demonstrate that our proposed method achieves better classification performances and also 
identifies more discriminative features, compared with the existing multi-modality based 
methods. Specifically, our proposed method achieves an accuracy of 95.92 % for 
classification between AD and HC, a high accuracy of 82.13 % for the classification 
between MCI and HC, and a high accuracy of 71.12 % for classification between MCI-C vs. 
MCI-NC.
Multi-modality based classification
Since different modalities may provide complementary information for diagnosis of AD 
(Apostolova et al. 2010; Landau et al. 2010), a lot of recent studies have investigated 
combining multi-modalities of data for AD diagnosis, showing improved classification 
performances (Walhovd et al. 2010; Bouwman et al. 2007; Wee et al. 2012; Ye et al. 2008; 
Davatzikos et al. 2011). For more comparisons, Table 4 lists the comparison between our 
proposed method and several other state-of-the-art methods for multi-modality based 
AD/MCI classification. For example, Huang et al. (Huang et al. 2011) proposed the sparse 
composite linear discriminant analysis (SCLDA) model performed on MRI and PET 
modalities of data, achieving the accuracy of 94.30 % for AD classification. Gray et al. 
(Gray et al. 2013) used four modalities (including MRI, PET, CSF and genetic) of data and 
achieved the accuracies of 89.00 %, 74.60 % and 58.00 % for classifying AD, MCI and 
MCI-C, respectively. Liu et al. (Liu et al. 2014) used two modalities including MRI and PET 
and achieved the accuracies of 94.40 %, 78.80 % and 67.80 % for classifying AD, MCI and 
MCI-C, respectively. As we can see from Table 4, our proposed method consistently 
outperforms the other state-of-the-art methods for multi-modality based classifications of 
AD, MCI, and MCI-C.
Effect of parameters
In our proposed model, there are two regularization terms including the group-sparsity 
regularizer and the discriminative regularizer. Accordingly, two regularization parameters 
(i.e., λ and σ) are used to balance the contributions of different terms. More specifically, λ 
is used to control the group sparsity of the model, and σ is used to balance the relative 
importance between the intra-class Laplacian matrix and the inter-class Laplacian matrix. 
Figure 6 gives the classification accuracies of our proposed method under different values of 
the parameter λ. For comparison, we also give the classification results of standard MTFS 
method (i.e., without the discriminative regularization term). Also, it is worth noting that 
when λ=0, no feature selection step is performed, i.e., all features are used for subsequent 
classification. In addition, we also test different values for the parameter σ, ranging from 0 
to 1 at a step size of 0.1, with a fixed λ value, as shown in Fig. 7.
As we can see from Fig. 6, under all values of λ, our proposed method significantly 
outperforms the MTFS method on all three classification tasks (i.e., AD vs. HC, MCI vs. HC 
and MCI-C vs. MCI-NC), which again shows the advantage of our method by introducing 
the discriminative regularization term based on the intra-class and inter-class Laplacian 
matrices. On the other hand, Fig. 7 indicates that the corresponding curves w.r.t different 
values of σ are very smooth on all the three classification tasks, showing a good robustness, 
i.e., insensitive to the values of σ.
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Comparsion with single model methods
Here, to estimate the effect of combining multi-modality image data and provide a more 
comprehensive comparison of the result from the proposed model, we further perform two 
experiments, that are (1) using only MRI modality, and (2) using only PET modality. It’s 
worth noting that our proposed model can also be used in single-modality case, where our 
model degrades into discriminative single-task (modality) feature selection followed by 
SVM classification. With corresponding results shown in Table 5. As can be seen from Table 
5, using multi-modalities (i.e., MRI+PET) achieves significantly better performances than 
only using single modality (MRI or PET).
Comparison with other feature selection methods
In order to further show the superiority of our proposed method, we compare it with other 
popular feature selection methods including RelieF (Kira and Rendell 1992) and Elastic Net 
(Zou and Hastie 2005). For fair comparison, we use the same classifier (i.e., multi-kernel 
SVM) after performing feature selection using RelieF, Elastic Net and our proposed method. 
Table 6 gives the classification accuracies of different feature selection methods for AD vs. 
HC, MCI vs. HC and MCI-C vs. MCI-NC, respectively. As we can see from Table 6, our 
proposed method always achieves the best classification accuracies in all the three 
classification tasks, compared to RelieF and Elastic Net. In particular, our proposed method 
exceeds nearly 10 percentage points than other two compared methods in the classification 
accuracy of MCI-C vs. MCI-NC. This result again validates the efficacy of our proposed 
method.
Limitations
The current study is limited by the following two factors. First, in this paper, we use two 
modalities, i.e., MRI and PET, for AD/MCI classification. However, there exist other 
modalities (e.g., CSF and APOE) which may also contain commentary information for 
further improving the classification performance. Second, we only consider two class 
classification problems (i.e., AD vs. HC, MCI vs. HC and MCI-C vs. MCI-NC), while did 
not test our proposed method for multi-class classification. In the future, we will address the 
above limitations to further improve the classification performance.
Conclusion
This paper proposed a discriminative multi-task feature selection method for classification of 
AD/MCI. Different from the existing multi-modality based feature selection methods, our 
proposed method explores both the distribution information of intra-class subjects and inter-
class subjects. Experimental results on the ADNI dataset show that our proposed method not 
only improves the classification performance, but also has potential to discover the disease-
related biomarkers useful for diagnosis of disease, in comparison with the state-of-the-art 
multi-modality based methods.
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Fig. 1. 
Overview of proposed method
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Fig. 2. 
The diagram of discriminative analysis
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Fig. 3. 
ROC curves of the classification performance of different methods in AD/MCI and HC
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Fig. 4. 
ROC curves of the classification performance of different methods in MCI-C and MCI-NC
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Fig. 5. 
Top 15 brain regions in MCI vs. HC classification
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Fig. 6. 
Classification accuracies under different values of λ
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Fig. 7. 
Classification accuracy with the change of discriminative parameter σ
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Table 2
The comparison of different methods for MCI converter classification
Method MCI-C vs. MCI-NC
ACC(%) SEN(%) SPE(%) AUC
SFFS 56.28 44.42 64.82 0.55
MML 61.67 54.19 66.96 0.61
MTFS 61.61 57.21 65.36 0.62
DMTFS(proposed) 71.12 67.21 73.93 0.68
ACC ACCuracy, SEN SENsitivity, SPE SPEcificity
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Table 3
Significance test on the classification accuracies between our proposed method and other methods
Compared method p-value
AD vs. HC MCI vs. HC MCI-C vs. MCI-NC
SFFS <0.0001 <0.0001 <0.0001
MML 0.0011 <0.0001 <0.0007
MTFS <0.0001 <0.0001 <0.0001
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Table 4
The comparison between proposed method and the state-of-the-art multi-modality based classification 
methods
Methods Modalities AD vs. HC MCI vs. HC MCI-C vs. MCI-NC
Huang et al. MRI+PET 94.30 % – –
Gray et al. MRI+PET+CSF+genetic 89.00 % 74.60 % 58.00 %
Liu et al. MRI+PET 94.40 % 78.80 % 67.80 %
DMTFS(proposed) MRI+PET 95.92% 82.13% 71.12%
ACC ACCuracy, SEN SENsitivity, SPE SPEcificity
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Table 6
The accuracies of different feature selection methods for AD, MCI and MCI-C classification
Methods AD vs. HC (%) MCI vs. HC (%) MCI-C vs. MCI-NC (%)
SFFS 91.26 72.91 60.00
RelieF(Dai et al. 2009) 93.46 76.89 63.89
Elastic Net(Del Sole et al. 2008) 89.62 75.70 61.61
Proposed method 95.92 82.13 71.12
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